Intranasal vaccination with RA 27-3 attenuated rubella virus.
D000328:Adult; D000336:Aerosols; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009666:Nose; D010919:Placebos; D011247:Pregnancy; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D012412:Rubella virus; D012996:Solutions; D014765:Viral Vaccines / Q000008:administration & dosage*
D000336:Aerosols; D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine; D012996:Solutions; D014765:Viral Vaccines